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Outcomes following repair of bileaﬂet prolapse due to myxomatous
disease of the mitral valve
E. Elmistekawy, V. Chan, D. Grisoli, M. Ruel, S. Chaudry, A. Tran,
L. Ressler, S. Lambert, T.G. Mesana
University of Ottawa Heart Institute, Ottawa, ON, Canada.
Objectives: Myxomatous disease represents the most common cause of
MR due to bileaﬂet prolapse. Mitral valve repair of mitral regurgita-
tion (MR) due to bileaﬂet prolapse poses many technical challenges.
In addition, late outcomes following repair are not well characterized
in this population. Published series have included mixed patient
cohorts and/or lacked long-term echocardiographic follow-up. And
thus constitutes the focus of the current study.
Methods: One-hundred thirty six patients (mean age 57.3 ± 17.5 years)
underwent mitral valve repair of bileaﬂet prolapse due to myxomatous
disease from 2002–2010. Concomitant CABG was performed in 16
(12%) patients. All patients were followed by a dedicated mitral valve
clinic with a follow-up interval that extended up to 6.6 years.
Results: There were no hospital deaths. Ring annuloplasty was used
for all patients. Additional mitral valve repair techniques included
chordal transfer (N ¼ 67), polytetraﬂuoroethylene neochords
(N ¼ 22), edge-to-edge repair, including lateral edge-to-edge repair
towards either commissure (N ¼ 30), or use of the hybrid-ﬂip over
technique (N ¼ 23). Prolapse involving more than one scallop of the
posterior leaﬂet was observed in 32 (24%) patients whereas prolapse
of more than one scallop of the anterior leaﬂet was observed in 56
(41%) patients. At follow-up, 3 patients had MRP2+, and no
patients required subsequent mitral valve re-intervention. Five-year
survival and freedom from recurrent (P2+) MR were 81.9 ± 2.7%
and 95.8 ± 2.7%, respectively.
Conclusions: Mitral valve repair of bileaﬂet prolapse due to myxoma-
tous disease is safe and durable. Successful repair often requires a com-
bination of surgical repair techniques.
http://dx.doi.org/10.1016/j.ehj.2013.12.050
Percutaneous mitral repair with-mitraclip system, safety and eﬃcacy;
initial Egyptian experience
Hazem Khamis, Ahmed Abdelaziz.
Objectives: To evaluate the feasibility, eﬃcacy, and safety of the
MitraClip system in patients with severe MR.
Background: Mitral valve repair for mitral regurgitation (MR) has
been performed by the use of a surgically created double oriﬁce.
Percutaneous repair based on this surgical approach has been
developed by use of the MitraClip device to secure the mitral
leaﬂets.
Methods: Five Patients with 3 to 4+ MR were selected in accordance
with the American Heart Association/American College of Cardiology
guidelines between March 2013 and May 2013 and underwent percuta-
neous mitral repair with MitraClip system . Patients were followed up
for six months after procedure. The primary acute safety endpoint was
freedom from major adverse events (MAEs) at 30 days, deﬁned as the
composite of death, myocardial infarction, non-elective cardiac sur-
gery for adverse events, renal failure, transfusion of more than 2 units
of blood, ventilation for more than 48 h, deep wound infection, septi-
cemia. The primary eﬃcacy endpoint is acute device success deﬁned as
clip implant with reduction of MR to equal or less than grade II, based
on current guidelines.
Results: A total of 5 patients were treated. No patients (0%) had a
major adverse event,. Freedom from clip embolization was 100%. Par-
tial clip detachment had not occurred in any patients (0%) patients.
Overall, 4 of 5 (80%) patients achieved acute procedural success,
and 3 (60%) were discharged with MR of 61+.
Conclusions: Our initial results with the MitraClip device in a very
small number of patients indicate that percutaneous edge-to edge
mitral valve repair is feasible and may be accomplished with favorable
short-term safety and eﬃcacy results.
http://dx.doi.org/10.1016/j.ehj.2013.12.051
Prediction of peri-procedural myocardial injury in patients undergoing
percutaneous coronary intervention by syntax score
Ahmed Fathy, Ghada Ibrahim, ELSayed Farag
Cardiology Department, Zagazig University, Egypt.
Background: Percutaneous coronary intervention (PCI) is well estab-
lished procedure for management of coronary artery disease. However,
up to 50% of cases associated with myocardial injury with subsequent
increased mortality. Currently there is no reliable method to predict
this injury.
Aim of the work: to investigate the ability of the syntax score to
predict peri-procedure myocardial injury (PMI) in patients undergo-
ing PCI. Patients and Methods: This study included 60 patients.
They are divided into two groups (1 = Non-diabetics) and
(2 = Diabetics) and subjected to: History and physical examination,
ECG, echocardiography, calculation of syntax score, PCI and tro-
ponin T.
Results: Our study shows highly signiﬁcant elevation in the troponin
level in both groups after PCI, this elevation was more in group (2)
(<0.001). In all study population the incidence of PMI was low in
patients with low syntax score and increased proportionally with the
increase in syntax score. We found the syntax score cutoﬀ value for
prediction of PMI to be 15 with calculated sensitivity of 95.3%,
speciﬁcity 88.2%, predictive value positive 95.3% and Predictive value
negative 88.2%.
Conclusion: Syntax score has the ability to predict the occurrence of
PMI with accepted sensitivity. It can assess the patient risk for
development of PMI which could help to rationalize the use of
adjunctive therapies as distal embolic protection devices in high risk
patients. Also, diabetic patients have higher incidence of compli-
cated coronary lesions, higher syntax score and they are more labile
for PMI.
http://dx.doi.org/10.1016/j.ehj.2013.12.052
Predictors of myocardial injury in patients with acute upper gastroin-
testinal bleeding
El-Sayed M Farag, Mohammad M Al-Daydamony, Yasser Al Naggar
Cardiology and Internal Medicine Departments, Faculty of Medicine,
Zagazig University, Egypt.
UPPER gastrointestinal bleeding (UGIB) is a common, potentially
life-threatening condition. Myocardial injury may complicate UGIB.
Previous studies were conducted to evaluate causes and consequences
of UGIB after acute myocardial infarction (AMI). Acute MI adds
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additional risk to already critically ill patients of UGIB and markedly
worsens their prognosis. However, little data are known about the pre-
diction of MI in patients with acute UGIB.
The aim of the work was to study the predictive risk factors for
acute myocardial infarction in patients with acute upper gastrointesti-
nal bleeding.
Subjects and methods: One hundred and ﬁve patients with UGIB (67
males and 38 females) with mean age of 52.9 ± 9.3 years were enrolled
in the study. Patients were excluded from the study if there was one or
more of the following: age younger than 35 years, initial systolic blood
pressure > 100 mmHg, initial hemoglobinP 12 gm/dl, history of pre-
vious ischemic heart disease, or contraindication for upper GIT
endoscopy.
All patients were submitted to full history taken and clinical exam-
ination, emergency upper gastrointestinal endoscopy, 12-leads electro-
cardiography (ECG), CK, CK-MB, Troponin I, complete blood
picture, liver and kidney function tests, bleeding proﬁle, arterial blood
gases and electrolytes, lipid proﬁle, fasting and postprandial blood glu-
cose level, abdominal ultrasonography, and echocardiographic
assessment.
According to the presence of myocardial injury, patients were
divided into two groups: Group I; included 66 patients without myo-
cardial injur. Group II: included 39 patients with myocardial injury.
Results: Population characteristics were comparable in all groups. In
patients with myocardial injury, there were signiﬁcantly more hyper-
tensive patients, more smokers, more patients with liver cirrhosis,
and more patients with rebleeding than among those without myocar-
dial injury.
In patients with myocardial injury, mean body mass index, mean
C-reactive protein, and mean hospital were signiﬁcantly higher than
in patients without myocardial injury.
Logistic regression analysis showed that the most signiﬁcant predic-
tors for myocardial injury in descending order were: hypertension
(score = 14.48, odd ratio = 7.057, p< 0.00001), cigarette smoking
(score = 10.425, odd ratio = 5.425, p< 0.0001), liver cirrhosis
(score = 7.845, odd ratio = 4.972, p = 0.0017), body mass
index > 25 kg/m2 (score = 7.132, odd ratio = 4.214,p= 0.0073),
and C-reactive protein level > 5 mg/dl (score = 6.321, odd
ratio = 3.986, p= 0.0159).
Conclusion: Among patients with UGIB, patients with myocardial
injury had signiﬁcantly more incidence of hypertension, smoking, liver
cirrhosis, and rebleeding than those without myocardial injury. Mean
body mass index, mean C-reactive protein level, and mean hospital
stay were signiﬁcantly higher in patients with myocardial injury.
The most signiﬁcant predictors for myocardial injury in patients
with UGIB in descending order were hypertension, cigarette smoking,
liver cirrhosis, body mass index > 25 kg/m2, and C-reactive protein
level > 5 mg/dl.
See Tables 1 and 2.
http://dx.doi.org/10.1016/j.ehj.2013.12.053
Preoperative anaemia is a risk factor for mortality and morbidity fol-
lowing aortic valve surgery
Elsayed Elmistekawy, Fraser Rubens, Chris Hudson, Bernard
Mcdonald, Marc Ruel, Khanh Lam, Thierry G. Mesana, Munir
Boodhwani.
Objectives: The impact of anaemia on patients undergoing aortic valve
surgery has not been well studied. We sought to evaluate the eﬀect of
anaemia on early outcomes following aortic valve replacement (AVR).
Methods: All patients undergoing non-emergent aortic valve surgery
(n ¼ 2698) with or without other concomitant procedures between
1997 and 2010 were included. Preoperative anaemia was deﬁned as
per World Health Organization guidelines as haemoglobin (Hb)
<130 g/l in men and Hb <120 g/l in women. Multivariable analyses
were used to determine the association between preoperative anaemia
and postoperative outcomes.
Results: The prevalence of preoperative anaemia was 32.2%. Patients
with anaemia were older (71 ± 12 vs 66 ± 13 years, P< 0.001), more
likely to have urgent surgery, recent MI, higher creatinine level and
impaired preoperative left ventricular function. Overall unadjusted
mortality was 2.8% in non-anaemic patients vs 8% in anaemic
patients. Anaemic patients were more likely to require renal replace-
ment therapy (11% vs 3%, P< 0.0001) and prolonged ventilation
(24% vs 10%, P< 0.0001). Following multivariable adjustment, lower
preoperative Hb was an independent predictor of mortality (odds ratio
Table 1
Comparison between two groups.
Group I ðn ¼ 66Þ Group II ðn ¼ 39Þ p
Age (ys) 52:8 9:2 52:9 8:2 >0.05
Sex Male 41 (62.1%) 26 (66.7%) >0.05
Female 25 (37.9 %) 13 (33.3%)
Diabetes 21 (31.8%) 11 (16.6%) >0.05
Hybertension 14 (21.2%) 26 (66.7 %) <0.00001
Smoking 20 (30.3%) 27 (69.2%) < 0.00l
NSAlDs use 20 (30.3%) 9 (23.1%) >0.05
Otteriode or terlipressine use 16 (24.2 %) 16(41%) >0.05
Body mats index (kg/m2) 22:9 4:2 28:8 4:5 <0.00001
Variceal bleeding 39 (59.l %) 28 (71.8 %) >0.05
Hemoglobin (gm/dL) 7:7 2:1 8:1 1:8 > 0.05
Leukocytic count (103/mm3) 7:9 2:2 7:9 2:3 >0.05
Plateler count (103/mm3) 221 104:8 210:1 79 >0.05
Urea (mg/dl) 47:7 3l:1 49:1 27:5 >0.005
creatinine (mg/dl) 1:12 0:62 1:2 0:71 >0.005
Total proteins (gm/dl) 6:9 0:6 6:8 0:6 >005
Serum albumin (gm/dl) 3:2 0:82 3 0:83 > 0.05
ALT (SGPT) (mg/dl) 39:7 18:5 37:7 17:3 >0.05
ALT (SGOT) (mg/dl) 49:5 21:2 44:2 22:3 >0.05
LDL (mg/dl) 115:9 25:4 121:7 24:8 >0.05
HDL (mg/dl) 43:5 7:6 44:4 8:2 >0.05
Triglycerides (mg/dl) 145:1 31:9 158 35:4 >0.05
C-reactive protein (mg/dl) 2:1 1:4 6:4 3:9 >0.00001
Total CK (U/L) 217:1 123 427:4 146:6 >0.00001
CKMB (ng/ml) 1:97 0:8 4:7 1:9 >0.00001
Troponin (ng/ml) 0:01 0:001 0:4 0:008 >0.00001
Liver cirrhosis 35 (53%) 31 (79.5%) 0.0067
LAD (mm) 28:7 10:5 31:2 7:3 >0.05
LVEDD (mm) 44:9 15:1 46:3 9:1 >0.05
LVESD (mm) 27:4 10 30:8 9:5 >0.05
EF (%) 62:4 18:5 58:7 12:4 >0.05
FS (%) 33:1 11:2 30:2 9:8 >0.05
Hospital stay (days) 4:3 1:5 8:5 3:5 <0.00001
Blood transfusions (units) 2:1 1:3 2:4 1:8 >0.05
Rebelleding 1 (1.5 %) 5 (12.8%) 0.016
Table 2
Predictors of myocardial injury.
Variable Score Odd ratio p
Hypertension 14.48 7.057 <0.00001
Smoking 10.425 5.425 <0.0001
Liver cirrhosis 7.845 4.972 0.0017
Body mass index > 25 kg/m2 7.132 4.214 0.0073
C-reactive protein level > 5 mg/dL 6.321 3.956 0.0159
Octereotide or terlipressin use 3.259 2.448 >0.05
NSAlDs use 2.865 1.986 >0.05
Age > 50 years 1.131 0.448 >0.05
Mile sex 0.965 0.321 >0.05
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